Search

everythinglearnresearchcommunity

for

Search:↓

Hydroxychloroquine may help treat benign prostatic hyperplasia by reducing inflammation and promoting cell death.

Dutasteride, fesoterodine, and finasteride are beneficial for older patients, while most other drugs should be used cautiously or avoided.

Estradiol may protect ear cells from hearing loss caused by a chemotherapy drug by activating a protective pathway.

Some synthesized compounds were more effective than Finasteride in reducing prostate cancer cell growth and androgen levels.

A new method creates unique chemical structures that could improve drug discovery.

The oral contraceptive alone is the preferred treatment for hirsutism, as adding the GnRH analog showed no significant benefit.

Inclisiran is effective at lowering cholesterol.

Certain cancer drugs can cause skin issues like rashes and itching.

Taking alfuzosin and finasteride together caused temporary vision loss in a glaucoma patient, but switching to tamsulosin helped.

Oral JAK inhibitors effectively treat alopecia areata and are generally well-tolerated.

EGFR inhibitors can cause skin issues like acne and dryness, but these can be managed without stopping treatment.

Erlotinib can cause acne-like skin issues, needing early treatment and possible dosage adjustments.

Certain medications can reduce mortality risk in COPD patients, but others can increase risks of cardiovascular issues, postoperative delirium, and other adverse effects.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

The combination of cyproterone acetate and testosterone enanthate is highly effective in preventing sperm production and could be a good reversible male contraceptive.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

HDAC inhibitors, like Vorinostat and Entinostat, can help regrow hair in alopecia areata.

Combination drug therapies are more effective for high-risk BPS patients but have more side effects and costs.

Cyproterone acetate with ethinyl estradiol is effective for treating skin symptoms related to high androgen levels, like in PCOS.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Bortezomib chemotherapy can cause temporary skin rashes.

Certain genetic variations are linked to higher liver enzyme levels in patients treated for chronic hepatitis C with specific drugs.

Imatinib can repigment grey hair, while SU11428 can cause temporary hair depigmentation.

Finasteride and tamsulosin hydrochloride can be safely taken together without significant interaction.

Some patients treated with peginterferon and ribavirin for chronic hepatitis C had mild to moderate skin reactions, but treatment did not need to be stopped.

RC48 shows promise for treating certain advanced cancers, but more research is needed.